Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Abbott Laboratories    ABT   US0028241000

Delayed Quote. Delayed Nyse - 05/22 04:01:48 pm
49.03 USD   -0.63%
05/18DJCredits & Debits
05/14 ABBOTT LABORATO : Enters into Agreement with GE Healthcare
05/13 ASTRAZENECA : Enters Companion Diagnostic Test Deal With Abbott
News SummaryMost relevantAll newsSector news 

Abbott Laboratories : Abbott and AbbVie Announce Investor Calls

01/14/2013 | 10:10am US/Eastern

Abbott Park, Illinois and North Chicago - Abbott (NYSE: ABT) will announce its fourth-quarter and full-year 2012 financial results on Wednesday, Jan. 23, 2013, before the market opens.

Abbott's quarterly and annual results will include contributions from the company's former research-based pharmaceutical business, which became AbbVie on Jan. 1, 2013. While these results will be captured in a single press release, both companies will host separate conference calls to discuss their respective business results and 2013 outlooks.

Abbott will host a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern) on Jan. 23, 2013. It will be accessible through Abbott's Investor Relations website at An archived edition of the call will be available after 11 a.m. Central time.

On Wednesday, Jan. 30, 2013, AbbVie will host a live webcast at 8 a.m. Central time (9 a.m. Eastern) accessible through AbbVie's Investor Relations website at An archived edition of the call will be available after 11 a.m. Central time.

About Abbott

Abbott (NYSE: ABT) is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 70,000 people.

About AbbVie

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. With its 125-year history, the company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. In 2013, AbbVie employs approximately 21,000 people worldwide and markets medicines in more than 170 Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.

Abbott Contacts:
Scott Stoffel

(847) 936-9502
Brian Yoor

(847) 937-6343
AbbVie Contacts:
Adelle Infante

(847) 938-8745
Larry Peepo

(847) 935-6722
distributed by
React to this article
05/21 ABBOTT LABORATORIES : Fitch Downgrades Abbotts's L-T IDR to 'A'; Outlook Revised..
05/21 ABBOTT LABORATORIES : Runners take on China's 'most-testing' marathon
05/20 ABBOTT LABORATORIES : ' Trademark Application for "NUTRITION IN CHARGE!" Filed
05/20 ABBOTT LABORATORIES : An Application for the Trademark "SIMILAC TUMMY CARE GUARA..
05/18DJCredits & Debits
05/15 BG MEDICINE : Reports First Quarter 2015 Financial Results
05/15 ABBOTT LABORATORIES : Reports from Biochemistry Laboratory Highlight Recent Find..
05/15 ABBOTT LABORATORIES : Researchers Submit Patent Application, "Use of Hmb to Impr..
05/14 ABBOTT LABORATORIES : ' Trademark Application for "OPTIGRO" Filed
Duration : Period :
Abbott Laboratories Technical Analysis Chart | ABT | US0028241000 | 4-Traders
Income Statement Evolution
More Financials